Evidence map›Paper›PMID 37773626›Full record

ArticleJMIR diabetes2023

Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study.

Uffe Søholm, Natalie Zaremba, Melanie Broadley, Johanne Lundager Axelsen, Patrick Divilly, Gilberte Martine-Edith, Stephanie A Amiel, Julia K Mader, Ulrik Pedersen-Bjergaard, Rory J McCrimmon and 9 more

Abstract read
In one paragraph

Article in JMIR diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Observational
  2. Article
  3. Review
  4. User evaluation of the Hypo-METRICS app: A tool for real-time symptom reporting of hypoglycaemia.Diabetic medicine : a journal of the British Diabetic Association · 2026
    Article
  5. Ecological momentary assessment in adolescents with type 1 diabetes: A mixed-methods feasibility study.Diabetic medicine : a journal of the British Diabetic Association · 2025
    Article
  6. Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Uffe SøholmMedical & Science, Patient Focused Drug Development, Novo Nordisk A/S, Søborg, Denmark.ORCID 0000-0003-0848-9421
Natalie ZarembaDepartment of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.ORCID 0000-0002-1720-1621
Melanie BroadleyDepartment of Psychology, University of Southern Denmark, Odense, Denmark.ORCID 0000-0003-4408-6304
Johanne Lundager AxelsenDepartment of Psychology, University of Southern Denmark, Odense, Denmark.ORCID 0000-0001-5718-3870
Patrick DivillyDepartment of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.ORCID 0000-0001-6916-3164
Gilberte Martine-EdithDepartment of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.ORCID 0000-0002-4592-3680
Stephanie A AmielDepartment of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.ORCID 0000-0003-2686-5531
Julia K MaderDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0001-7854-4233
Ulrik Pedersen-BjergaardDepartment of Endocrinology and Nephrology, Nordsjællands Hospital Hillerød, Hillerød, Denmark.ORCID 0000-0003-0588-4880
Rory J McCrimmonSystems Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.ORCID 0000-0002-3957-1981
Eric RenardDepartment of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, Montpellier, France.ORCID 0000-0002-3407-7263
Mark EvansWelcome-MRC Institute of Metabolic Science and Department of Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-8122-8987
Bastiaan de GalanDepartment of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands.ORCID 0000-0002-1255-7741
Simon HellerDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-2425-9565
Christel HendrieckxSchool of Psychology, Institute for Health Transformation, Deakin University, Geelong, Australia.ORCID 0000-0002-0075-828X
Pratik ChoudharyDepartment of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.ORCID 0000-0001-7635-4735
Jane SpeightDepartment of Psychology, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-1204-6896
Frans PouwerDepartment of Psychology, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-8172-9818
Hypo-RESOLVE consortiumSee Acknowledgements, .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Hypoglycaemia - MEasurement, ThResholds and ImpaCtS (Hypo-METRICS) smartphone app was developed to investigate the impact of hypoglycemia on daily functioning in adults with type 1 diabetes mellitus or insulin-treated type 2 diabetes mellitus. The app uses ecological momentary assessments, thereby minimizing recall bias and maximizing ecological validity. It was used in the Hypo-METRICS study, a European multicenter observational study wherein participants wore a blinded continuous glucose monitoring device and completed the app assessments 3 times daily for 70 days.

objectiveThe 3 aims of the study were to explore the content validity of the app, the acceptability and feasibility of using the app for the duration of the Hypo-METRICS study, and suggestions for future versions of the app.

methodsParticipants who had completed the 70-day Hypo-METRICS study in the United Kingdom were invited to participate in a brief web-based survey and an interview (approximately 1h) to explore their experiences with the app during the Hypo-METRICS study. Thematic analysis of the qualitative data was conducted using both deductive and inductive methods.

resultsA total of 18 adults with diabetes (type 1 diabetes: n=10, 56%; 5/10, 50% female; mean age 47, SD 16 years; type 2 diabetes: n=8, 44%; 2/8, 25% female; mean age 61, SD 9 years) filled out the survey and were interviewed. In exploring content validity, participants overall described the Hypo-METRICS app as relevant, understandable, and comprehensive. In total, 3 themes were derived: hypoglycemia symptoms and experiences are idiosyncratic; it was easy to select ratings on the app, but day-to-day changes were perceived as minimal; and instructions could be improved. Participants offered suggestions for changes or additional questions and functions that could increase engagement and improve content (such as providing more examples with the questions). In exploring acceptability and feasibility, 5 themes were derived: helping science and people with diabetes; easy to fit in, but more flexibility wanted; hypoglycemia delaying responses and increasing completion time; design, functionality, and customizability of the app; and limited change in awareness of symptoms and impact. Participants described using the app as a positive experience overall and as having a possible, although limited, intervention effect in terms of both hypoglycemia awareness and personal impact.

conclusionsThe Hypo-METRICS app shows promise as a new research tool to assess the impact of hypoglycemia on an individual's daily functioning. Despite suggested improvements, participants' responses indicated that the app has satisfactory content validity, overall fits in with everyday life, and is suitable for a 10-week research study. Although developed for research purposes, real-time assessments may have clinical value for monitoring and reviewing hypoglycemia symptom awareness and personal impact.

Indexed as

content validitydiabetesecological momentary assessmenthypoglycemiamobile phonesmartphone app

Identifiers

PMID37773626
PMCPMC10576226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.